Schreib, K.M.; Bräm, D.S.; Zeilhofer, U.B.; Müller, D.; Güngör, T.; Krämer, S.D.; Hauri-Hohl, M.M.
Population Pharmacokinetic Modeling for Twice-Daily Intravenous Busulfan in a Large Cohort of Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation—A 10-Year Single-Center Experience. Pharmaceutics 2024, 16, 13.
https://doi.org/10.3390/pharmaceutics16010013
AMA Style
Schreib KM, Bräm DS, Zeilhofer UB, Müller D, Güngör T, Krämer SD, Hauri-Hohl MM.
Population Pharmacokinetic Modeling for Twice-Daily Intravenous Busulfan in a Large Cohort of Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation—A 10-Year Single-Center Experience. Pharmaceutics. 2024; 16(1):13.
https://doi.org/10.3390/pharmaceutics16010013
Chicago/Turabian Style
Schreib, Katharina M., Dominic S. Bräm, Ulrike Barbara Zeilhofer, Daniel Müller, Tayfun Güngör, Stefanie D. Krämer, and Mathias M. Hauri-Hohl.
2024. "Population Pharmacokinetic Modeling for Twice-Daily Intravenous Busulfan in a Large Cohort of Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation—A 10-Year Single-Center Experience" Pharmaceutics 16, no. 1: 13.
https://doi.org/10.3390/pharmaceutics16010013
APA Style
Schreib, K. M., Bräm, D. S., Zeilhofer, U. B., Müller, D., Güngör, T., Krämer, S. D., & Hauri-Hohl, M. M.
(2024). Population Pharmacokinetic Modeling for Twice-Daily Intravenous Busulfan in a Large Cohort of Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation—A 10-Year Single-Center Experience. Pharmaceutics, 16(1), 13.
https://doi.org/10.3390/pharmaceutics16010013